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Abstract
Introduction:  Dilated  pupil  is  an  important  factor  for  good  visualization  during  pars  plana  vitrec-
tomy (PPV)  in  patients  with  diabetic  retinopathy.  Despite  its  side  effects,  intravitreal  adrenaline
has been  used  to  maintain  pupil  dilation.
Objective:  To  assess  the  effect  of  intravitreal  adrenaline  infusion  on  pupil  dilation  in  patients
with diabetic  retinopathy  undergoing  PPV.
Methods:  This  study  included  30  eyes  of  30  patients  with  progressive  diabetic  retinopathy
underwent  PPV.  Pupils  of  all  eyes  were  dilated  by  topical  application  of  a  combination  of  1%
tropicamide  and  2.5%  phenylephrine,  and  eyes  were  randomized  1:1  to  continuous  intravitreous
infusion  of  adrenaline  (0.5  mg/500  ml  in  balanced  salt  solution)  or  vehicle  control.  Surgical  pro-
cedures were  recorded  with  a  high  deﬁnition  video  recorder.  Normalized  pupillary  area  (NPA)
was measured  on  recorded  images  before  and  at  the  end  of  surgery.
Results:  Post-operative  NPA  differed  signiﬁcantly  between  the  two  groups  (p  =  0.04).  By  con-
trast, pre-operative  NPA  (p  =  0.81)  and  changes  in  NPA  (p  =  0.17)  did  not.
Conclusion:  Intravitreal  infusion  of  adrenaline  did  not  have  a  signiﬁcant  effect  on  pupil  dilation,
compared  with  non-adrenaline,  in  patients  with  diabetic  retinopathy  undergoing  PPV.
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La  eﬁcacia  de  la  adrenalina  intravítrea  continua  como  adyuvante  midriático
en  la  vitrectomía  pars  plana  en  el  paciente  diabético,  un  ensayo  clínico  aleatorizado
Resumen
Introducción:  La  dilatación  de  la  pupila  es  un  factor  importante  para  una  buena  visualización
durante la  vitrectomía  pars  plana  (VPP)  en  pacientes  con  retinopatía  diabética.  A  pesar  de  sus
efectos secundarios,  la  adrenalina  intravítrea  se  ha  utilizado  para  mantener  la  dilatación  de  la
pupila.
Objetivo: Evaluar  el  efecto  de  la  infusión  de  adrenalina  en  la  dilatación  de  la  pupila  intravítrea
en pacientes  con  retinopatía  diabética  sometidos  a  VPP.
Métodos:  En  este  estudio  se  incluyeron  30  ojos  de  30  pacientes  con  retinopatía  diabética  pro-
gresiva que  se  sometieron  a  VPP.  Las  pupilas  de  todos  los  ojos  estaban  dilatadas  por  aplicación
tópica de  una  combinación  del  1%  de  tropicamida  y  fenilefrina  al  2.5%,  y  los  ojos  fueron  asigna-
dos al  azar  1:1  a  infusión  continua  intravítrea  de  adrenalina  (0.5  mg/500  ml  en  solución  salina
equilibrada)  o  a  control  de  vehículo.  Los  procedimientos  quirúrgicos  se  registraron  con  un
grabador de  vídeo  de  alta  deﬁnición.  El  área  pupilar  normalizada  (NPA)  se  midió  en  las  imágenes
grabadas  antes  y  al  ﬁnal  de  la  cirugía.
Resultados:  La  NPA  postoperatoria  difería  signiﬁcativamente  entre  los  2  grupos  (p  =  0,04).  Por
el contrario,  en  lo  referente  a  la  NPA  antes  de  la  operación  (p  =  0,81)  y  después  de  los  cambios
en la  NPA  (p  =  0,17)  no  hubo  esas  diferencias  entre  grupos.
Conclusión:  La  infusión  de  adrenalina  intravítrea  no  tuvo  un  efecto  signiﬁcativo  sobre  la  dila-
tación de  la  pupila,  en  comparación  con  los  casos  de  no  infusión  de  adrenalina,  en  pacientes
con retinopatía  diabética  sometidos  a  VPP.
© 2016  Sociedad  Mexicana  de  Oftalmolog´ıa.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es
un art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Ontroduction
aintaining  a  dilated  pupil  during  pars  plana  vitrectomy
PPV)  is  an  important  factor  for  good  visualization  during
urgery,  particularly  for  patients  with  diabetic  retinopathy.
ecause  diabetic  patients  show  a  small  resting  pupil  and
eak  mydriasis  response,  eyes  of  diabetic  patients  undergo-
ng  PPV  are  frequently  treated  with  continuous  intravitreal
nfusions  of  adrenaline,  diluted  in  balanced  salt  solution
BSS),  to  maintain  pupillary  dilation.1,2 Adrenaline  is  fre-
uently  added  to  the  indwelling  posterior  segment  infusion
uring  vitreoretinal  procedures  in  order  to  maintain  peri-
perative  mydriasis  and  assist  with  hemostasis.3 Previous
tudy  shows  that  adrenaline  in  the  intraocular  infusion
as  beneﬁcial  effect  in  maintaining  mydriasis  in  cataract
urgery.4
Adrenaline,  however,  was  shown  to  induce  the  synthe-
is  of  endogenous  prostaglandins,  which  can  disrupt  the
lood-retinal  barrier  and  cause  cystoid  macular  edema.5,6
drenaline  has  also  been  found  to  signiﬁcantly  reduce  blood
ow  to  the  optic  nerve  head  and  have  cardiovascular  adverse
ffects.7 This  study  investigated  the  ability  of  continuously
nfused  intravitreal  adrenaline  to  maintain  pupil  dilation
uring  PPV  in  patients  with  diabetic  retinopathy.
ubjects and methodsPlease  cite  this  article  in  press  as:  Kartasasmita  AS,  et  al.  T
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his  study  was  a  randomized  control  trial  involving  30  eyes
f  30  patients  with  diabetic  retinopathy  who  underwent
PV  at  Cicendo  Eye  Hospital.  Written  informed  consent  was
t
m
t
abtained  from  each  patient,  and  the  study  protocol  was
pproved  by  the  Ethics  Committee  of  the  Faculty  of  Medicine
f  Padjadjaran  University.
Consecutive  patients  were  enrolled  and  randomized  1:1
sing  block  permutation  to  the  treatment  (adrenaline)
nd  control  (non-adrenaline)  groups,  each  consisting  of
5  patients.  Adrenaline  solution  for  intravitreal  infusion
onsisted  of  0.5  mg  adrenaline  dissolved  in  500  ml  BSS.  Each
upil  was  dilated  by  topical  application  of  one  drop  of  tropi-
amide  1%  and  one  drop  of  phenylephrine  2.5%  three  times
ach  at  60,  45,  and  30  min  before  surgery.
All  surgical  procedures  were  recorded  with  a  high  deﬁ-
ition  video  recorder.  Eye  parameters  were  measured  using
y  Sketch  Up  Pro  on  photos  of  each  recording,  which  had
een  edited  with  Adobe  Photoshop.  Pupillary  dilation  was
etermined  by  measuring  normalized  pupillary  area  (NPA),
eﬁned  as  pupillary  horizontal  diameter  divided  by  limbal
orizontal  diameter  in  millimeters  (Fig.  1).  NPA  was  mea-
ured  twice  in  each  eye,  before  and  after  surgery,  and  the
ifference  was  calculated.  NPA  was  measured  by  individ-
als  blinded  to  subject  allocation.  Statistical  analyses  were
erformed  using  SPSS® software.
esults
f  the  30  patients  included  in  this  study,  15  were  randomizedhe  effectiveness  of  continuous  intravitreal  adrenaline  as
nt,  a  randomized  clinical  trial.  Rev  Mex  Oftalmol.  2016.
o  the  adrenaline  group  and  15  to  the  control  group.  Their
ean  ages  were  53.7  years  and  53.4  years,  respectively,  and
here  were  no  signiﬁcant  between-group  differences  in  age
nd  gender  distribution.  The  most  common  diagnosis  in  the
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Captured image with 5 mm ruler as reference
Editing proses consist of treshod adjusment (Left) and image inverting (right) using Adobe photoshop
NPA Measurement using Sketch Up Pro software. NPA is calculated using formula : NPA = 
PA/LA
PA = Pupil area
LA = Limbus areaPlease  cite  this  article  in  press  as:  Kartasasmita  AS,  et  al.  T
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Figure  1  NPA  Mhe  effectiveness  of  continuous  intravitreal  adrenaline  as
nt,  a  randomized  clinical  trial.  Rev  Mex  Oftalmol.  2016.
easurement.
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Table  1  Characteristics  of  the  study  subjects.
Characteristics  Group  P  value
Adrenaline  (n  =  15)  Non  adrenaline  (n  =  15)
Gender  (mean  ±  SD)
Male  6  (40%)  6  (40%)  --
Female 9  (60%)  9  (60%)
Age (mean  ±  SD)  53.7  (7.8)  53.4  (6.0)  0.90
Diagnosis
VH ec  PDR  7  (46.7%)  4  (26.7%)  --
TRD ec  PDR  5  (33.3%)  3  (20%)
VH et  TRD  ec  PDR 3  (20%)  7  (46.7%)
Combined  RD  ec  PDR  0  (0%)  1  (16.6%)
History of  PRP
Yes  10  (66.7%)  3  (20%)  0.01
No 5  (33.3%)  12  (80%)
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retinal photocoagulation.
drenaline  group  was  vitreous  hemorrhage  due  to  progres-
ive  diabetic  retinopathy  (PDR;  46.7%)  and  the  most  common
iagnoses  in  the  control  group  were  vitreous  hemorrhage
nd  tractional  retinal  detachment  due  to  PDR  (46.7%).  Ten
66.7%)  patients  in  the  adrenaline  group  and  three  (20%)  in
he  control  group  had  a  history  of  pan-retinal  photocoagu-
ation  (p  =  0.01).  Table  1  shows  the  detailed  characteristics
f  the  study  subjects.
Although  NPA  before  surgery  was  similar  in  the  adrenaline
nd  control  groups  (0.65  vs.  0.61,  p  =  0.17),  NPA  was  signif-
cantly  higher  after  surgery  in  the  adrenaline  than  in  the
ontrol  group  (0.66  vs.  0.60,  p  =  0.04).  Mean  differences  in
PA  were  similar  in  the  two  groups  (Table  2).
iscussion
iabetic  patients  have  smaller  sized  pupils  and  weaker  dila-
ion  than  healthy  individuals.8 These  alterations  in  diabetic
atients  are  caused  by  sympathetic  nerve  neuropathy  and
egenerative  changes  in  pupillary  dilator  muscle.  Degen-
rative  changes  have  been  observed  in  smooth  muscle,Please  cite  this  article  in  press  as:  Kartasasmita  AS,  et  al.  T
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erve  endings,  and  connective  tissues  of  diabetic  irises.9
lectron  microscopy  showed  that,  in  diabetic  individuals,
athologic  changes  were  greater  in  pupillary  dilator  muscles
han  in  pupillary  sphincter  muscle.10 Glycogen  accumulation
t
b
s
t
Table  2  Measurement  of  normalized  pupillary  area  (NPA)  and  du
Adrenaline  (n  =  15)  
NPA  prior  to  PPV  (mean  ±  SD)  0.65  (0.08)  
NPA after  PPV  (mean  ±  SD)  0.66  (0.07)  
Difference of  NPA  (mean  ±  SD)  0.034  (0.026)  
Duration of  PPV  (mean  ±  SD)  34.8  (11.7)  
NPA, normalized pupillary area. tractional retinal detachment; RD, retinal detachment; PRP, pan
y  pigment  epithelial  layer  was  also  documented  in  diabetic
rises.11
In  a  dark  environment,  pupillary  size  in  diabetic  patients
s  inversely  proportional  to  both  the  duration  of  diabetes
nd  blood  glucose  level.  Duration  of  diabetes  in  this  study
as  uncertain,  since  most  study  subjects  could  not  accu-
ately  determine  the  time  of  disease  onset,  and  others  were
ound  to  have  diabetes  on  diagnosis  of  diabetic  retinopathy.
iabetes  can  be  determined  by  measuring  blood  levels  of
lucose  and  HbA1C,  a  marker  for  control  of  glucose  level.
owever,  most  of  the  subjects  in  this  study  were  not  checked
heir  level  of  HbA1C.  Therefore,  this  is  considered  as  one  of
he  limitations  of  this  study.
This  study  found  that  treatment  with  adrenaline  did
ot  signiﬁcantly  alter  pupil  response  in  the  two  groups.
drenaline  has  a  short  half-life  of  2--3  min  and  is  rapidly
liminated  through  body  organs.  In  addition,  contractions
f  the  pupillary  dilator  muscle  are  mediated  by  the  1
eceptor  located  in  this  muscle.  This  muscle  embryologically
riginated  from  the  anterior  iris,  along  with  blood  vessels
nd  nerves  that  supplied  the  muscle.  The  administration
f  adrenaline  by  intravitreal  infusion  in  this  study  assumedhe  effectiveness  of  continuous  intravitreal  adrenaline  as
nt,  a  randomized  clinical  trial.  Rev  Mex  Oftalmol.  2016.
hat  ﬂow  from  the  anterior  segment  to  the  anterior  iris  was
locked  by  a  barrier  consisting  of  the  posterior  lens  cap-
ule  and  anterior  hyaloid.  All  of  the  subjects  included  in
his  study  were  phakic.  Thus  results  may  differ  if  subjects
ration  of  PPV.
Group  P  value
Non  adrenaline  (n  =  15)
0.61  (0.08)  0.17
0.60  (0.08)  0.04
0.037  (0.044)  0.81
33.3  (10.6)  0.72
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are  aphakic  or  if  the  posterior  lens  capsule  and  anterior
hyaloid  are  not  intact,  a  barrier  deprivation  that  can  cre-
ate  a  communication  between  the  vitreous  and  anterior
chambers  (3).  Intravitreal  adrenaline  is  an  1  agonist  that
acts  on  pupillary  dilator  muscle.  However,  following  topical
application  of  2.5%  phenylephrine,  an    adrenergic  agonist,
adrenaline  cannot  bind  to  its  receptors  at  times  shorter  than
its  half-life  (2--3  h).
The  results  of  this  study  differed  from  those  of
another  assessing  the  effects  of  intravitreal  infusion  of
two  adrenaline  concentrations,  0.5  and  1  mg/500  ml,  on
pupillary  diameter.7 That  previous  study  found  that  both
adrenaline  doses  resulted  in  signiﬁcant  pupil  dilation,  but
most  subjects  had  already  undergone  cataract  surgery  and
their  lens  status  and  posterior  capsule  were  unreported.  For
example,  an  aphakic  lens  and/or  a  posterior  lens  rupture
could  result  in  ‘‘barrier  deprivation’’,  creating  a  commu-
nication  between  the  anterior  and  posterior  segments  and
affecting  the  pharmacokinetics  of  intravitreal  adrenaline.
Lens  status  (aphakia  or  pseudophakia)  also  contributes  to
differences  in  pupillary  size.
Pupillary  dilation  response  may  also  be  inﬂuenced  by
other  factors,  including  age.  Older  age  has  been  associated
with  pupillary  myosis  and  decreased  sympathetic  tone  of  the
pupillary  dilator  muscle.12 However,  in  this  study,  there  was
no  difference  in  age  distribution  between  the  treatment  and
control  groups.  Pupillary  response  to  drugs  that  dilate  pupils
depended  on  iris  color,  as  determined  by  race.  Dark  irises
contain  more  melanin  pigment,  making  it  harder  to  dilate
their  pupils  using  a  standard  dose  of  the  drugs.  A  study  of  the
mydriatic  effects  of  phenylephrine,  cyclopentolate,  scopol-
amine,  homatropine,  and  atropine  on  blue,  brown  and  dark
irises,  depending  on  race  showed  that  phenylephrine  was
ineffective  as  a  mydriatic  agent  on  eyes  from  black  subjects.
By  contrast,  treatment  with  scopolamine,  homatropine,  and
cyclopentolate  resulted  in  approximately  equal  degrees  of
mydriasis  in  the  three  races  studied.13--15 Because  our  sub-
jects  did  not  differ  in  race,  outcomes  associated  with  race
were  not  determined.
Eyes  of  diabetic  patients  show  a  weak  pupillary  dilation
response  to  instillation  of  anticholinergic  drugs,  but  hyper-
sensitivity  to  adrenergic  drugs.  The  decreased  sympathetic
tone  in  patients  with  diabetic  retinopathy  may  explain  why
additional  instillation  of  a  sympathomimetic  agent,  such  as
phenylephrine,  can  cause  a  diabetic  pupil  to  become  hyper-
sensitive,  resulting  in  combinations  of  anticholinergic  and
sympathomimetic  agents  achieving  adequate  dilation  in  dia-
betic  patients.13,15 This  became  the  basis  of  preoperatively
instilling  combinations  of  cycloplegic  (e.g.,  tropicamide)
and  sympathomimetic  (e.g.,  phenylephrine)  agents  to  dilate
the  pupil,  as  in  this  study.
The  ability  to  dilate  the  pupil  is  reduced  in  diabetic
retinopathy  patients  who  have  already  undergone  pan-
retinal  photocoagulation  (PRP).  It  remains  unclear,  however,
whether  PRP  itself  is  responsible  or  whether  the  severity  of
diabetic  retinopathy  made  the  diabetic  pupil  more  resistant
to  mydriatic  drugs.  In  this  study,  the  proportion  of  subjects
with  a  history  of  PRP  was  larger  in  the  adrenaline  than  inPlease  cite  this  article  in  press  as:  Kartasasmita  AS,  et  al.  T
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the  control  group.
Pupillary  dilation  response  on  images  can  be  estimated
by  counting  pixels  present  in  pupils  using  round  or  elliptical
j
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tting  or  by  assessing  NPA.2 The  optimal  method  of  measur-
ng  pupillary  area  has  not  been  determined,  although  NPA
s  reported  to  be  superior  to  counting  pixels  and  ellipse  ﬁt-
ing  because  it  minimizes  noise  in  the  periphery  pupil  and
imbus.16,17
NPA  was  also  measured  in  this  study  because  of  inter-
ndividual  differences  in  pupil  structure  and  the  ability  to
ilate  and  constrict  the  pupil,  thus  affecting  iris  response
o  light  stimuli  and  drugs.  This  condition  must  be  controlled
or  during  comparisons  of  pupillary  responses  among  indi-
iduals.  For  example,  under  scotopic  conditions,  papillary
onstriction  will  be  lower  in  individuals  with  a  pupillary
iameter  of  3 mm  than  5  mm.  Thus,  signiﬁcant  pupillary
onstriction  may  be  independent  of  retinal  and  optic  nerve
onditions.
The  effectiveness  of  intravitreal  adrenaline  infusion  in
aintaining  pupillary  dilation  was  determined  by  measuring
ifferences  in  NPA  before  and  after  surgery,  with  differences
n  the  difference  of  NPA  compared  between  the  adrenaline
nd  control  groups.  Although  the  difference  of  NPA  did  not
iffer  signiﬁcantly  between  the  two  groups,  postoperative
PA  differed  signiﬁcantly.  This  may  have  been  due  to  the
ffects  of  tamponade  with  gas  or  air,  the  tamponades  most
requently  used  during  PPV  surgery,  especially  for  tractional
etinal  detachment  due  to  diabetic  retinopathy.  Injection  of
as  or  air  as  a  tampon  will  enlarge  pupil  diameter.
Intraocular  pressure  (IOP)  can  also  affect  pupillary  size.
OP  will  be  higher  at  the  end  of  surgery,  due  to  an  increased
nfusion  pressure  of  approximately  25--30  mmHg  performed
o  prevent  leakage  from  a  sclerotomy  wound.  This  condition
ill  result  in  a  larger  pupil  diameter  at  the  end  of  surgery.
he  effects  of  tamponade  and  IOP  on  pupil  diameter  may
ave  introduced  bias  in  this  study.
The  duration  of  PPV  surgery  can  also  alter  the  effects
f  mydriatic  drugs  and  dilation  response.  A  longer  duration
f  surgery  can  also  increase  surgical  trauma,  including  the
elease  of  prostaglandins,  neuropeptides  such  as  substance
 and  calcitonin,  enhancing  miosis  in  diabetic  irises.  The
ean  duration  of  surgery  was  similar  in  the  adrenaline  and
ontrol  groups  (34.8  vs.  33.3  min,  p  =  0.72).  All  subjects  in
his  study  were  administered  topical  tropicamide  1%  and
henylephrine  2.5%,  starting  approximately  60  min  before
urgery,  to  dilate  their  pupils.  The  mean  duration  of  the
upillary  dilation  procedure  and  surgery  was  94  min.  Tropi-
amide  was  effective  for  6  h  and  phenylephrine  for  2--3  h,
ndicating  that  the  entire  procedure  was  performed  while
he  drugs  were  effective.
This  study  had  several  limitations.  The  ﬁrst  is  the  method
sed  to  measure  pupil  size.  That  is,  the  position  of  the  eye
r  eye  movement  will  affect  the  angle  between  the  camera
nd  the  eye,  altering  the  number  of  pixels  captured  by  the
amera  and  the  shape  of  the  circle  or  line  ﬁtted  onto  the
upil.  A  lower  camera  position  will  result  in  an  apparently
arger  sized  pupil.18 This  situation  can  be  minimized  by  posi-
ioning  the  eye  using  forceps  so  that  it  is  perpendicular  to
he  camera  when  the  picture  is  taken.  The  pharmacokinetics
f  intravitreal  adrenaline  are  also  affected  by  lens  status,
ntact  posterior  lens  capsule  and  anterior  hyaloid.  All  sub-he  effectiveness  of  continuous  intravitreal  adrenaline  as
nt,  a  randomized  clinical  trial.  Rev  Mex  Oftalmol.  2016.
ects  in  this  study  had  phakic  lenses.  Studies  are  needed  to
ompare  the  effects  of  intravitreal  adrenaline  on  phakic,
seudophakic  eye  and  aphakic  eyes.
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In  conclusion,  intravitreal  infusion  of  adrenaline  did  not
igniﬁcantly  alter  pupillary  dilation  during  PPV  surgery  in
atients  with  diabetic  retinopathy.
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